Diabetes collaboration to identify biomarkers

Ezose Sciences and Merck have signed a collaboration to look at changes in glycans, the sugar part of the protein-sugar complexes found on the surfaces of cells, in order to find potential biomarkers for diabetes. This project is an extension of an existing agreement, and uses Ezose's proprietary GlycanMap platform. Glycans, which make up the glycome (all the sugars found in the body, either alone or as part of other molecules), have many roles in health and disease and could have potential as targets for new therapeutics, as well as markers for diagnostics. Release (.pdf)

Suggested Articles

Johnson & Johnson Vision announced that the worldwide president of its surgical business, Tom Frinzi, plans to retire at the end of this year.

Philips looked back on 15 years of data from one of its telehealth-equipped intensive care units, where centralizing operations reduced mortality.

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.